** = Publications listed in SCI/SSCI/Pubmed
** Birngruber, T; Prietl, B; Bodenlenz, M; Florian, P; Subramaniam, A; Kainz, S; Rauter, G; Pieber, TR; Sinner, F
Continuous sampling of immune cells in the skin by dermal open flow microperfusion
J INVEST DERMATOL. 2017; 137(10):S275-S275.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.684
[Poster]
Web of Science
FullText
FullText_MUG
** Bodenlenz, M; Prietl, B; Florian, P; Subramaniam, A; Kainz, S; Rauter, G; Pieber, TR; Sinner, F
Characterization of the Psoriasis-like Inflammation in the Imiquimod Rat Model using Dermal Open Flow Microperfusion
J INVEST DERMATOL. 2017; 137(10):S278-S278.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.698
[Poster]
Web of Science
FullText
FullText_MUG
** Narula, N; Kainz, S; Petritsch, W; Haas, T; Feichtenschlager, T; Novacek, G; Eser, A; Vogelsang, H; Reinisch, W; Papay, P
The efficacy and safety of either infliximab or adalimumab in 362 patients with anti-TNF-α naïve Crohn's disease.
Aliment Pharmacol Ther. 2016; 44(2):170-80
Doi: 10.1111/apt.13671
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG